Diphtheria: Causes, Symptoms, Treatment & Prevention

What Is Diphtheria?

Diphtheria is a serious and contagious bacterial infection that typically affects the throat and nose, though it can impact other areas of the body as well. The condition causes a distinctive thick, grey coating to form in the affected areas, leading to significant breathing and swallowing difficulties. While diphtheria is now rare in developed countries due to widespread vaccination programs, it remains a serious health concern in areas with limited access to healthcare and immunization services.

The disease is treatable when diagnosed early, but it can become life-threatening if left untreated or if complications develop. In the United States, diphtheria has become increasingly uncommon thanks to the routine use of the diphtheria vaccine and improved living conditions. However, understanding this disease remains important for healthcare providers and the general public, as outbreaks can still occur in unvaccinated populations.

Historical Context and Current Prevalence

Diphtheria was once a leading cause of childhood death in the United States and many other countries. The diphtheria epidemic peaked in 1921 in the U.S. with 206,000 reported cases. However, the introduction and widespread adoption of the diphtheria vaccine dramatically changed the epidemiological landscape. Today, diphtheria is extremely rare in the United States and other developed nations with robust vaccination programs. Nevertheless, many countries with limited healthcare infrastructure or vaccination accessibility continue to experience higher rates of diphtheria, making it an ongoing global public health concern.

Causes and Transmission

Diphtheria is caused by a bacterium called Corynebacterium diphtheriae. This pathogenic bacterium adheres to the lining of your airways and produces a potent toxin that damages respiratory tissue cells. The bacterium spreads from person to person through respiratory droplets released when an infected individual coughs, sneezes, or talks. Additionally, diphtheria can be transmitted through direct contact with open sores or ulcers on the skin of an infected person.

The transmission of diphtheria makes it a significant concern in crowded environments or settings where people are in close contact. Understanding these transmission routes is crucial for preventing the spread of infection and implementing appropriate infection control measures in healthcare and community settings.

Pathophysiology and Disease Development

Once Corynebacterium diphtheriae establishes infection, the bacteria release a toxin that initiates a destructive process. Within a few days of infection, dead tissue accumulates and forms a characteristic thick, grey or greyish-white coating. This pseudomembrane can cover tissues in the voice box, throat, nose, and tonsils. The buildup of this coating can progressively obstruct the airway, making breathing and swallowing increasingly difficult. In severe cases, this obstruction can become life-threatening, requiring emergency medical intervention.

Beyond the respiratory complications, the diphtheria toxin can cause systemic damage to other organ systems. The toxins can affect the heart, kidneys, and nervous system, leading to serious complications such as myocarditis, renal dysfunction, and neurological damage. Understanding this pathophysiology helps explain why prompt diagnosis and treatment are so critical.

Risk Factors for Exposure

Several factors increase the risk of exposure to diphtheria:

• Being unvaccinated or incompletely vaccinated against diphtheria
• Living in or traveling to areas with limited vaccination coverage
• Close contact with infected individuals or carriers of the bacterium
• Living in crowded or unsanitary conditions
• Being in healthcare settings where infected patients are being treated
• Compromised immune system function
• Exposure to individuals from endemic areas

Symptoms and Clinical Presentation

The symptoms of diphtheria typically develop within two to seven days of infection and may include:

• Sore throat and difficulty swallowing
• Breathing difficulty or shortness of breath
• The characteristic thick, grey coating in the throat or nose
• Fever and chills
• Enlarged lymph nodes in the neck
• Hoarseness or change in voice
• Nasal congestion or drainage
• Skin sores or ulcers (in cutaneous diphtheria)
• Weakness and fatigue
• Rapid or irregular heartbeat

Respiratory diphtheria, affecting the nose and throat, is the most common form and can be very serious. The severity of symptoms can vary, with some individuals experiencing mild symptoms while others develop rapidly progressive and life-threatening disease.

Potential Complications

Diphtheria can lead to serious complications if not promptly treated:

• Pneumonia: Lung infection resulting from the spread of infection or from aspiration
• Lung failure or respiratory failure: Severe airway obstruction or impaired respiratory function requiring mechanical ventilation
• Paralysis: Neurological complications affecting muscle function, including facial and breathing muscles
• Heart problems: Myocarditis and heart failure caused by the diphtheria toxin
• Kidney damage: Renal dysfunction from systemic toxin effects
• Death: About 1 in 10 people who get diphtheria die from the disease, even with treatment

Even with appropriate medical treatment, these complications can result in death, underscoring the severity of this infection and the critical importance of prevention through vaccination.

Diagnosis

Healthcare providers diagnose diphtheria based on a combination of clinical symptoms and laboratory testing. A definitive diagnosis typically involves taking a sample from the back of the throat or from a skin sore using a swab. This sample is then sent to a laboratory for testing to identify the presence of Corynebacterium diphtheriae bacteria. Healthcare providers may sometimes begin treatment based on clinical suspicion before laboratory results are confirmed, given the serious nature of the disease and the importance of early intervention.

The clinical presentation, including the characteristic grey membrane and respiratory symptoms, combined with laboratory confirmation, establishes the diagnosis of diphtheria.

Treatment Approaches

Diphtheria treatment begins immediately upon diagnosis and often even before laboratory confirmation is complete. Treatment typically involves two main components:

Diphtheria Antitoxin: This medication is administered to neutralize the toxin produced by the bacteria and prevent further damage to organs. Early administration of antitoxin is crucial for limiting complications and improving outcomes.

Antibiotics: Antibiotics are prescribed to eliminate the bacterial infection. Common antibiotics used in diphtheria treatment include penicillin or erythromycin. In most cases, patients become non-contagious approximately 48 hours after starting antibiotic therapy.

Hospitalization is typically required for diphtheria management. Patients are placed in isolation rooms to prevent transmission to others. The complete treatment course usually takes approximately two to three weeks to be fully effective. Skin ulcers resulting from cutaneous diphtheria can take several months to heal completely. Supportive care, including management of respiratory complications and monitoring for cardiac issues, is also an important part of treatment.

Prevention Through Vaccination

Vaccination is the most effective way to prevent diphtheria. The diphtheria vaccine is highly effective, with a prevention rate exceeding 87% after three doses. The vaccine works by training your immune system to recognize and fight off the diphtheria bacterium before infection occurs.

The United States uses three main types of combination vaccines that include protection against diphtheria:

• DTaP vaccine: Protects against diphtheria, tetanus, and pertussis (whooping cough), given to children under age 7
• Tdap vaccine: A booster vaccine for older children, adolescents, and adults, containing reduced doses of diphtheria and pertussis
• Td vaccine: Contains diphtheria and tetanus protection for individuals who cannot receive the pertussis component

Vaccination Schedule

Young children should receive the DTaP vaccine a total of five times at the following ages:

• 2 months
• 4 months
• 6 months
• 15-18 months
• 4-6 years

After age 12, most people should receive a diphtheria booster vaccine once every 10 years. This ongoing protection is essential for maintaining immunity throughout life.

Vaccine Effectiveness

Research has demonstrated that the diphtheria vaccine components in DTaP, DT, Td, and Tdap vaccines are extremely effective, achieving approximately 95% effectiveness against diphtheria for up to 10 years. The diphtheria vaccine is over 87% effective at preventing symptomatic disease when a complete series is administered.

Side Effects of Diphtheria Vaccination

Most people do not experience severe problems after receiving a diphtheria vaccination. However, some individuals may develop mild side effects that usually resolve on their own within a few hours or days:

• Redness, swelling, or soreness at the injection site
• Low-grade fever
• Mild body aches
• Fatigue
• Headache
• Nausea

Serious side effects are rare. Healthcare providers and patients should discuss any concerns about vaccine reactions with medical professionals.

Community Immunity and Public Health Impact

When most people in a community receive the diphtheria vaccine, the entire community benefits from increased protection. This concept, known as herd immunity or community immunity, helps prevent disease spread even among individuals who cannot be vaccinated due to medical contraindications. Maintaining high vaccination rates in communities is therefore essential for protecting vulnerable populations.

When to Seek Medical Attention

If you or your child develops symptoms suggestive of diphtheria, particularly difficulty breathing, severe sore throat with a grey coating, or rapid onset of respiratory distress, seek emergency medical care immediately. Early diagnosis and treatment significantly improve outcomes and reduce the risk of serious complications or death.

Frequently Asked Questions

Q: Is diphtheria still a threat in developed countries?

A: While diphtheria is extremely rare in developed countries with high vaccination rates, it remains a potential threat in unvaccinated populations and in areas with limited access to vaccines. International travel and population movements can introduce the disease to previously unaffected areas.

Q: How often do I need a diphtheria booster?

A: Most adults should receive a diphtheria booster vaccine once every 10 years, typically as part of the Tdap or Td vaccine.

Q: Can you get diphtheria even if vaccinated?

A: While rare, it is still possible to get diphtheria after receiving the vaccine, though symptoms are typically less severe and may not last as long as in unvaccinated individuals.

Q: What should I do if I am exposed to diphtheria?

A: If you believe you have been exposed to diphtheria, contact your healthcare provider immediately. They may recommend prophylactic antibiotics or evaluate your vaccination status to determine if a booster is needed.

Q: Why is diphtheria so rare now?

A: Diphtheria is rare in developed countries primarily due to widespread vaccination programs that have achieved high community immunity levels and improved living conditions.

Similar Articles

Alarming Rise in Self-Harm in Young People

Alarming Rise in Self-Harm in Young People

Skin Signs Of Non-Accidental Injury: Expert Guide For Clinicians

Lichen Simplex Of The Scrotum: Diagnosis And Treatment

Labial Adhesion In Prepubertal Girls: What Parents Need To Know

Thrush In Men: 5 Signs, Causes, And Treatment Options

Author

Sneha TeteBeauty & Lifestyle Writer

 

Sneha is a relationships and lifestyle writer with a strong foundation in applied linguistics and certified training in relationship coaching. She brings over five years of writing experience to renewcure,  crafting thoughtful, research-driven content that empowers readers to build healthier relationships, boost emotional well-being, and embrace holistic living.

Read full bio of Sneha Tete